Infliximab Preferentially Induces Clinical Remission and Mucosal Healing in Short Course Crohn’s Disease with Luminal Lesions through Balancing Abnormal Immune Response in Gut Mucosa

Table 4

Efficacy of IFX therapy on fistula of CD patients.

Variable		Remission group; (failed/total)	Response group; (failed/total)	Failure group; (failed/total)
Perianal	28	3/15	1/5	7/8
Enterocutaneous	3	0/2	0/1	0/0
Enterovaginal	3	0/1	1/1	1/1
Intestinal^a	12	0/1	2/2	8/9
Total^b	46	3/19	4/9	16/18

Two patients with intestinal fistula also had a perianal fistula.
^bP 0.01 by chi-square test.